Erectile Dysfunction Drugs Market Share

Statistics for the 2023 & 2024 Erectile Dysfunction Drugs market share, created by Mordor Intelligence™ Industry Reports. Erectile Dysfunction Drugs share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Erectile Dysfunction Drugs Industry

The erectile dysfunction drugs market is fragmented in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold market shares and are well known including Apricus Biosciences Inc., Bayer AG, Eli Lilly and Company, Ferring Pharmaceuticals, GlaxoSmithKline PLC, Metuchen Pharmaceuticals LLC, S.K. Chemicals Co. Ltd, Teva Pharmaceutical Industries Ltd, and VIVUS Inc., among others.

Erectile Dysfunction Drugs Market Leaders

  1. Pfizer Inc.

  2. GlaxoSmithKline plc.

  3. Bayer AG

  4. Eli Lilly and Company

  5. Lupin

*Disclaimer: Major Players sorted in no particular order

Erectile Dysfunction Drugs Market Concentration

Erectile Dysfunction Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)